MAP2K7 and melanoma: Nowadays, there are two treatment modalities for advanced melanoma: molecular targeted therapy (inhibitors of BRAF and MEK kinases; BRAFi/MEKi) and immunotherapy with the usage of immune checkpoint inhibitors (anti-PD-1, -CTLA-4, and -LAG-3 antibodies).